PharmaLundensis Investor Relations Material
Latest events
Q1 2025
15 May, 2025
Q4 2024
12 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from PharmaLundensis
Access all reports
PharmaLundensis AB is a Sweden-based biotechnology company focused on developing treatments and solutions for respiratory diseases. The company specializes in research aimed at addressing chronic obstructive pulmonary disease (COPD) and related conditions. In addition to its pharmaceutical development activities, PharmaLundensis explores environmentally friendly methods for reducing medical waste and chemical emissions in healthcare. The company is headquartered in Lund, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
PHAL
Country
🇸🇪 Sweden